Harraz OF, Brett SE, Welsh DG. Nitric oxide suppresses vascular voltage-gated T-type Ca 2ϩ channels through cGMP/PKG signaling. Am J Physiol Heart Circ Physiol 306: H279 -H285, 2014. First published November 15, 2013 doi:10.1152/ajpheart.00743.2013Recent reports have noted that T-type Ca 2ϩ channels (CaV3.x) are expressed in vascular smooth muscle and are potential targets of regulation. In this study, we examined whether and by what mechanism nitric oxide (NO), a key vasodilator, influences this conductance. Using patch-clamp electrophysiology and rat cerebral arterial smooth muscle cells, we monitored an inward Ba 2ϩ current that was divisible into a nifedipine-sensitive and -insensitive component. The latter was abolished by T-type channel blocker and displayed classic T-type properties including faster activation and steady-state inactivation at hyperpolarized potentials. NO donors (sodium nitroprusside, S-nitroso-N-acetyl-dl-penicillamine), along with activators of protein kinase G (PKG) signaling, suppressed T-type currents. Inhibitors of guanylyl cyclase/PKG {1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and KT5823, respectively}, had no effect on basal currents; KT5823 did, however, mask T-type Ca 2ϩ channel current inhibition by NO/PKG. Functional experiments confirmed an inhibitory effect for NO on the T-type contribution to cerebral arterial myogenic tone. Cumulatively, our findings support the view that T-type Ca 2ϩ channels are a regulatory target of vasodilatory signaling pathways. This targeting will influence Ca 2ϩ dynamics and consequent tone development in the cerebral circulation.
voltage-gated Ca 2ϩ channels; NO; Ca 2ϩ regulation; PKG; vascular smooth muscle cells ARTERIAL TONE IS REGULATED by multiple stimuli including tissue metabolism (9) , humoral/neural agents (4, 10) , and intravascular pressure (15) . These stimuli influence vasomotor activity in part by altering cytosolic [Ca 2ϩ ] in arterial smooth muscle cells (6, 11) . Cytosolic [Ca 2ϩ ] is primarily set by resting membrane potential and steady-state Ca 2ϩ influx through voltage-gated Ca 2ϩ channels (16, 27) . While L-type Ca 2ϩ channel expression predominates (3, 15) , recent studies have noted that T-type Ca 2ϩ channels are additionally present. Of particular note, the T-type conductance is thought to influence arterial diameter when vessels sit at more hyperpolarized potentials (1, 17) . There are three subtypes of T-type Ca 2ϩ channels, and in rat cerebral vascular smooth muscle, both Ca V 3.1 and Ca V 3.2 are expressed (1) . Intriguingly, a recent electrophysiological assessment has noted that vascular T-type Ca 2ϩ channels are a target of regulation, with PKA signaling being specifically shown to suppress this conductance (12) . In light of these findings and earlier studies, it is conceived that other vasodilatory pathways including those linked to nitric oxide (NO) may also inhibit vascular T-type Ca 2ϩ channels (14) . Such inhibition could, in theory, be mediated through classical cGMP/protein kinase G (PKG) signaling (25) , S-nitrosylation (18) , or oxidative stress (14) .
The goal of this study was to determine whether T-type Ca 2ϩ channels are regulatory targets of NO in cerebral arterial smooth muscle. Using patch-clamp electrophysiology and smooth muscle cells from rat cerebral arteries, we report for the first time that vascular T-type currents are directly targeted and suppressed by NO. Pressure myography confirmed that NO application limits T-type channel contribution to myogenic tone. Subsequent work revealed that NO-induced suppression was mediated through the classical PKG signaling cascade. In closing, this suppressive ability of NO to the T-type conductance is thought to facilitate cerebral vasodilation either directly by restraining Ca 2ϩ entry through the T-type pores or indirectly by altering membrane potential regulation (13) .
MATERIALS AND METHODS
Animal procedures and cell isolation. Animal procedures were approved by the Animal Care Committee at the University of Calgary. Briefly, female Sprague-Dawley rats (10 -12 wk of age) were euthanized by CO 2 asphyxiation. Brains were removed, placed in cold phosphate-buffered saline (pH 7.4), and the middle/posterior cerebral arteries were dissected free of surrounding tissues. Smooth muscle cells were enzymatically isolated as previously described (2) . Briefly, arterial segments (ϳ2 mm in length) were placed in a medium (37°C, 10 min) containing (in mM) 60 NaCl, 80 Na ϩ glutamate, 5 KCl, 2 MgCl 2, 10 glucose, and 10 HEPES with 1 mg/ml albumin (pH 7.4). Vessels were then exposed to a two-step enzymatic digestion: 1) 15-min incubation in medium (37°C) containing 0.5 mg/ml papain and 1.5 mg/ml dithioerythritol and 2) 10-min incubation in medium containing 100 M Ca 2ϩ , 0.7 mg/ml type-F collagenase, and 0.4 mg/ml type-H collagenase. Tissues were washed and triturated; liberated cells were stored on ice for use within ϳ6 h.
Electrophysiology. Conventional patch-clamp electrophysiology was used to monitor whole cell currents in isolated smooth muscle cells as reported earlier (12) . Recording electrodes (5-8 M⍀) were pulled from borosilicate glass microcapillary tubes (Sutter Instruments, Novato, CA) using a micropipette puller (Narishige PP-830, Tokyo, Japan), and backfilled with pipette solution containing (in mM) 135 CsCl, 5 Mg-ATP, 10 HEPES, and 10 EGTA (pH 7.2). Cells were voltage clamped and equilibrated in bath solution consisting of (in mM) 110 NaCl, 1 CsCl, 10 BaCl 2, 1.2 MgCl2, 10 glucose, and 10 HEPES (pH 7.4). A NaCl-agar bridge was used between the reference electrode and the bath solution. Whole cell currents were recorded using an Axopatch 200B patch-clamp amplifier (Molecular Devices, Sunnyvale, CA), filtered at 1 kHz, digitized at 5 kHz, and were stored on a computer for off-line analysis with Clampfit 10.3 software (Molecular Devices). Whole cell capacitance averaged 13-17 pF, and all electrophysiological experiments were performed at room temperature (ϳ22°C).
To record whole cell currents, isolated cells held at Ϫ60 mV were exposed to a prepulse (Ϫ90 mV, 200 ms) and then voltage steps ranging from Ϫ50 to ϩ40 mV (10 mV interval, 300 ms). Currentvoltage (I-V) relationships were plotted either as peak current (in pA) or current density (in pA/pF) or as normalized currents (I/I max). Time constants () of activation, inactivation, and deactivation were obtained using Clampfit 10.3 software by standard exponential fitting of the activating, inactivating, and deactivating segments, respectively (12) . For activation time constants, the downward segment (from 0 pA to peak at 10 mV) was fitted. To calculate inactivation, the inactivating segment (50 ms) at 10 mV was exponentially fitted. Deactivating tail currents were elicited by hyperpolarization from ϩ10 to Ϫ60 mV to obtain deactivation time constants. Voltage-dependence of steadystate inactivation was assessed by the protocol: 1) prepulse to Ϫ90 mV, 2) stepping from Ϫ70 to 20 mV (10-mV intervals, 1.5 s each), 3) brief hyperpolarizing step (Ϫ90 mV, 10 ms), and 4) test pulse of 10 mV (200 ms). Currents elicited by test pulse were normalized to maximal current (I/I max). To assess the voltage dependence of activation, isochronal tail currents were monitored. In particular, cells held at Ϫ60 mV were prepulsed to Ϫ90 mV (300 ms), followed by voltage steps (Ϫ80 to 40 mV, 50 ms) and a test pulse (Ϫ90 mV, 200 ms) to evoke tail currents.
Experimental protocols. Voltage protocols were run on isolated cells bathed in solutions containing 10 mM Ba . Consistent with past investigations, nifedipine (200 nM) was used to fully abolish L-type Ca 2ϩ channel activity (12, 20) . The residual T-type currents were subsequently monitored in the absence (control) and presence of 1) NNC 55-0396
The SNAP-and db-cGMP-mediated modulation of T-type Ca 2ϩ channels was also assessed in cells pretreated with KT5823.
Pressurized vessel myography. Endothelial denuded cerebral arteries were mounted in a customized arteriograph and superfused with warm (37°C) physiological saline solution as previously described (1). External diameter was monitored using an automated edge detection system (IonOptix, Milton, MA). Following equilibration, intravascular pressure was increased incrementally from 15 to 50 mmHg, and arteries were then superfused with 200 nM nifedipine. The dilatory response to NNC 55-0396 was then monitored in the absence or presence of SNAP (10 M). Each protocol was followed by the addition of a Ca 2ϩ free physiological saline solution (0 externally added Ca 2ϩ ϩ 2 mM EGTA). Statistical analysis. Data are expressed as means Ϯ SE, and n indicates the number of cells or vessels. Paired or unpaired t-tests were performed, where appropriate, to compare the effects of treatment on whole cell current. P values Ͻ 0.05 were considered statistically significant. Averaged current-voltage relationships were fitted to the following peak Gaussian function:
where I max is peak current (I), Vmax is V at Imax, and b is the slope of the distribution. The voltage dependencies of activation and steadystate inactivation were described with single Boltzmann distributions of the following forms:
where Imax is the maximal activatable current, V50 is the voltage at which the current is 50% activated or inactivated, and k is the slope (voltage dependence) of the distribution.
Chemicals and drugs.
Nifedipine, NNC 55-0396, SNP, EGTA, and buffer reagents were purchased from Sigma-Aldrich (St. Lois, MO). Dibutyryl cyclic-GMP and SNAP were obtained from Enzo Life Sciences (Farmingdale, NY) and Invitrogen (Eugene, OR), respectively. ODQ and KT5823 were acquired from Tocris Bioscience (Minneapolois, MN) and Calbiochem (Gibbstwon, NJ), respectively.
RESULTS AND DISCUSSION
Isolation of the T-type conductance in cerebral arterial smooth muscle. Using arterial smooth muscle cells isolated from rat cerebral arteries, we started with monitoring whole cell currents. To augment charge flow through L-type (Ca V 1.2) and T-type (Ca V 3.1/Ca V 3.2) channels, this study monitored whole cell currents in 10 mM Ba 2ϩ (12) . In the presence of this charge carrier, a robust voltage-dependent inward current was observed (Fig. 1A) . Subsequent addition of 200 nM nifedipine, a dihydropyridine that blocks the vascular Ca V 1.2 splice variant with an IC 50 of ϳ10 -15 nM (12, 20) , reduced the whole cell conductance by 75%. This dihydropyridine-mediated reduction has been shown earlier to arise from full abolishment of L-type current while exerting negligible effect, if any, on T-type channels (12) . Three lines of evidence indicated that T-type channels dominate the residual nifedipine-insensitive current. First, the putative T-type blocker NNC 55-0396 fully inhibited this remaining component (Fig. 1A) . Second, the voltage dependence of normalized plots of whole cell currents along with steady-state inactivation/activation showed that the NNC-sensitive component of the whole cell current was hyperpolarized shifted (ϳ15 mV) compared with the nifedipinesensitive component (Fig. 1, B and C) . Lastly, kinetic analysis revealed that nifedipine quickened the rates of inactivation and activation while slowing that of deactivation (Fig. 1, D and E) . Note that while the properties of this isolated T-type current are comparable with other native vascular cells (17, 21) , they are rightward shifted compared with T-type conductances monitored in other cell types or expression systems (22) . As shown earlier, these shifts are primarily attributable to the use of 10 mM Ba 2ϩ as the charge carrier and the subsequent screening effect and preferential augmentation of L-type (over T-type) channel activity (12) . While Ba 2ϩ (10 mM) should trigger a T-type current similar to that obtained in 10 mM Ca 2ϩ solutions, the latter would induce smooth muscle cell contraction, making stable electrical recordings difficult. To summarize, experiments outlined in Fig. 1 confirmed the successful isolation of a current component predominantly carried by T-type channels.
NO suppresses T-type Ca 2ϩ channels. T-type Ca 2ϩ channels represent key regulatory targets for a range of hormones and neurotransmitters in different tissues (19, 26) . These modulatory effects are typically, although not exclusively, mediated through G protein signaling linked to protein kinases A, G, C, and calmodulin-dependent kinase II (28) . With that said, electrophysiological regulatory observations in native vascular smooth muscle remain limited, with one exception being recent work documenting a suppressive effect of ␤-adrenergic/PKA signaling on T-type channel (12) . These observations intriguingly raise the possibility that other vasodilatory pathways, for example, NO signaling, could also inhibit T-type channels.
Functional vascular studies have recently alluded to a role for NO modulation of T-type Ca 2ϩ channels (8, 24, 14) . In the cerebral circulation, this view arose from observations showing 
Bottom traces (magnified): differential kinetics of activation (left) and inactivation (right).
The time interval to Imax was shorter in the presence of nifedipine. The extent of voltagedependent inactivation, over similar time intervals, was greater after nifedipine. E: Time constants () of activation, inactivation, and deactivation before and after nifedipine application. *P Ͻ 0.05, significant difference from control values (n ϭ 11, paired t-test). that the T-type contribution of the myogenic response was enhanced in a rat model of acute NO inhibition (14) . In line with these vasomotor observations, the overall contribution of T-type Ca 2ϩ channels to cerebral arterial tone development was suppressed by the preapplication of NO donors (Fig. 2, A and B). The T-type component, defined by sensitivity to NNC 55-0396, was attenuated from 12% (control) to 5% (SNAPpretreated) of the maximal response. We hypothesize based on this change and the documented Ca 2ϩ response to intravascular pressure (15) that NO suppression of the T-type conductance would reduce the global rise in cytosolic [Ca 2ϩ ] by ϳ10 -15 nM. While the [Ca 2ϩ ] and vasomotor changes are modest, previous computational modeling indicates that they are sufficient to reduce network blood flow by 20 -35% (1) . Although the functional data suggest that NO could conceivably modulate T-type Ca 2ϩ channels, direct electrical evidence remains lacking.
In this context, we isolated cerebral arterial smooth muscle cells and sought to test our hypothesis that NO acutely modulates the T-type electrical conductance through cGMP/PKG signaling. We present two sets of electrophysiological observations supporting the view that this vasoactive molecule elicits an inhibitory effect on T-type channels through classical PKG signaling. First, bath application of different NO donors (SNP or SNAP) suppressed the nifedipine-insensitive T-type inward current (Fig. 2, C and D) . Interestingly, a cell-permeable PKG activator (db-cGMP) evoked comparable suppression (Fig. 2D) , suggesting a direct modulatory role for NO/ cGMP/PKG cascade. This suppression peaked ϳ15 min postincubation and coincided with a slight but significant hyperpolarized shift in steady-state inactivation (Fig. 2, E and  F) . Matching time controls revealed no significant changes in T-type current amplitude, a finding consistent with past reports showing that the T-type conductance, unlike the L-type, is rundown resistant (12) . Interestingly, blockade of PKG signaling using the kinase inhibitor KT5823 or the GC inhibitor ODQ had no direct effect on the amplitude of the basal T-type current or its voltage dependence (Fig. 3, A-D) . Even though and as a second line of evidence, preincubating smooth muscle cells with KT5832 attenuated the ability of SNAP (Fig. 4, A and B) and db-cGMP (Fig. 4, C and D) to suppress T-type channel activity. The sensitivity of SNAP (NO)-mediated inhibition to PKG blockade reemphasized a direct modulatory role for NO through cGMP/PKG pathway. In summary, our electrophysiological observations are the first to demonstrate that vascular T-type channels are directly targeted by NO signaling through GC/cGMP/PKG pathway.
Physiological/pathological implications. Previous reports including our own have reported a role of T-type Ca 2ϩ channels in setting cerebral arterial tone (1, 17) . Of particular note is the purported ability of the T-type conductance to drive myogenic tone when vessels sit at more hyperpolarized potentials around Ϫ50 mV (1). In theory, Ca 2ϩ entry through T-type Ca 2ϩ channels could set arterial tone through one of two general mechanisms (13) . First, it could directly contribute to the rise in cytosolic [Ca 2ϩ ], a process that would enhance myosin light chain phosphorylation via the activation of myosin light chain kinase (6, 11) . On the other hand, Ca 2ϩ influx through the T-type pores could indirectly elevate cytosolic [Ca 2ϩ ] by locally modulating Ca 2ϩ -activated channels that set resting membrane potential (13) . Potential targets include the Ca tone development in the cerebral circulation. Such regulation may be compromised under conditions of endothelial dysfunction where NO bioavailability is decreased. This loss of NOinduced suppression may interestingly be one of the underlying mechanisms of cerebral vasospasm and could also contribute to impaired tissue perfusion observed during hypertension and diabetes (23) . Summary. In conclusion, the present study delineated T-type Ca 2ϩ channels and tested whether this conductance is modulated by NO/PKG signaling in rat cerebral arteries. We employed patch-clamp electrophysiology to isolate a non-L-type whole cell current that was sensitive to T-type blockers and exhibited electrical characteristics of T-type Ca 2ϩ channels. We subsequently showed for the first time that vascular T-type channels represent a direct regulatory target of the putative vasodilator NO through classical cGMP/PKG signaling. The latter was confirmed using both electrophysiological and pressurized vessel myography experiments. This selective targeting may implicate NO/PKG/Ca V 3.x signaling in controlling smooth muscle function through direct control of cytosolic [Ca 2ϩ ] or indirect modulation of membrane potential. 
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